Discovery and in Vitro Development of AIDS Antiviral Drugs as Biopharmaceuticals
- 1 January 1995
- book chapter
- Published by Elsevier
- Vol. 33, 389-438
- https://doi.org/10.1016/s1054-3589(08)60675-4
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Human immunodeficiency virus uses tRNALys,3 as primer for reverse transcription in HeLa‐CD4+ cellsFEBS Letters, 1994
- High Affinity Binding of TAR RNA by the Human Immunodeficiency Virus Type-1 tat Protein Requires Base-pairs in the RNA Stem and Amino Acid Residues Flanking the Basic RegionJournal of Molecular Biology, 1993
- Purification of HIV-1 wild-type protease and characterization of proteolytically inactive HIV-1 protease mutants by pepstatin A affinity chromatographyFEBS Letters, 1991
- Cis elements and Trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1Journal of Molecular Biology, 1990
- Involvement of tryptase‐related cellular protease(s) in human immunodeficiency virus type 1 infectionFEBS Letters, 1989
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Development of Antiretroviral Therapy for the Acquired Immunodeficiency Syndrome and Related DisordersNew England Journal of Medicine, 1987
- Treatment of Herpesvirus InfectionsNew England Journal of Medicine, 1983
- A detailed model of reverse transcription and tests of crucial aspectsCell, 1979